---
annotations:
- id: PW:0000641
  parent: regulatory pathway
  type: Pathway Ontology
  value: gluconeogenesis pathway
- id: PW:0000640
  parent: classic metabolic pathway
  type: Pathway Ontology
  value: glycolysis pathway
- id: PW:0000025
  parent: classic metabolic pathway
  type: Pathway Ontology
  value: glycolysis/gluconeogenesis pathway
- id: PW:0000262
  parent: classic metabolic pathway
  type: Pathway Ontology
  value: altered metabolic pathway
- id: PW:0001021
  parent: disease pathway
  type: Pathway Ontology
  value: melanoma pathway
- id: PW:0000026
  parent: classic metabolic pathway
  type: Pathway Ontology
  value: citric acid cycle pathway
authors:
- Khanspers
- Egonw
citedin: ''
communities: []
description: Key metabolic pathways in melanoma, glycolytic pathway, TCA cycle, glutamine
  metabolism, and oxidative phosphorylation, with potential therapeutic targets and
  inhibitors. Inhibitors targeting critical metabolic nodes are outlined in teal.   This
  pathway is based on [Figure 1 in Shen et al](https://www.nature.com/articles/s41420-025-02617-3).
last-edited: 2025-12-16
ndex: null
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5609
- /instance/WP5609
- /instance/WP5609_r142203
revision: r142203
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5609.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Key metabolic pathways in melanoma, glycolytic pathway, TCA cycle,
    glutamine metabolism, and oxidative phosphorylation, with potential therapeutic
    targets and inhibitors. Inhibitors targeting critical metabolic nodes are outlined
    in teal.   This pathway is based on [Figure 1 in Shen et al](https://www.nature.com/articles/s41420-025-02617-3).
  keywords:
  - 2-AAPA
  - 2-Deoxy-D-glucose
  - ACSS1
  - ARAF
  - AZD2014
  - 'AZD3965 '
  - AZD8055
  - Acetate
  - Acetyl-CoA
  - BPTES
  - BRAF
  - CB-839
  - CPT1A
  - Citric acid
  - DCA
  - DET
  - DETD-35
  - DLAT
  - DLD
  - Etomoxir
  - FA-CoA
  - FK866
  - Fructose 1,6-bisphosphate
  - Fructose 6P
  - Fumarate
  - G6PD
  - GLS
  - GMKX1778
  - GPX4
  - GSR
  - GSSG
  - Gamitrinib
  - Glucose
  - Glucose-6P
  - Glutamate
  - Glutamine
  - Glutathione
  - Indole-5,6-quinone
  - Isocitric acid
  - L-DON
  - L-DOPA
  - L-Tyrosine
  - LDHA
  - LDHB
  - Lactate
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MITF
  - MLST8
  - MTOR
  - Malate
  - NAD
  - NADP
  - NADPH
  - NAM
  - NAMPT
  - NMN
  - OPi
  - Oxaloacetate
  - P-enolpyruvate
  - PDHA1
  - PDK
  - PFKFB2
  - PGLS
  - PKLR
  - PKM1
  - PKM2
  - PPARGC1A
  - Phenformin
  - Pyruvate
  - RAF1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPTOR
  - SLC16A1
  - SLC16A3
  - SLC1A5
  - SLC2A1
  - SR-18292
  - Succinate
  - TRAP1
  - XCT790
  - alpha-Ketoglutaric acid
  - succinyl-CoA
  license: CC0
  name: Inhibitors of metabolism in melanoma therapy
seo: CreativeWork
title: Inhibitors of metabolism in melanoma therapy
wpid: WP5609
---